TG Therapeutics Net Non-Operating Interest Income Expense (Quarterly) Insights

TG Therapeutics, Inc. (TGTX)

29.82 +0.07 (+0.24%) USD | NASDAQ | Dec 31, 16:00

30.00 +0.18 (+0.60%) After-Hours: 20:00

View Net Non-Operating Interest Income Expense (Quarterly) for TGTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	Upgrade
Karyopharm Therapeutics, Inc.	Upgrade
Axsome Therapeutics, Inc.	Upgrade
Krystal Biotech, Inc.	Upgrade
Arcutis Biotherapeutics, Inc.	Upgrade